Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02448303
Title Pembrolizumab Alone and In Combination With ACP-196 in Subjects With Advanced Non-small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Acerta Pharma BV
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Western Regional Medical Center/Cancer Treatment Center of America Goodyear Arizona 85338 United States Details
*Shaded cells indicate that there was no data available from for the field